Earnings Recap - July 07, 2026 (EOD)

 ## Today's Earnings Scorecard The earnings season continued with a mix of strong beats and notable misses across various sectors. Tech and healthcare stocks showed particular volatility as investors digested the latest results and outlooks. Notably, Crinetics Pharmaceuticals surged nearly 99% following a major acquisition announcement, while Rivian’s shares declined sharply amid a large capital raise and cautious revenue guidance. Samsung's blockbuster profit failed to calm AI-related valuation concerns, triggering a broader chip sector selloff. Meanwhile, SpaceX’s inclusion in the Nasdaq-100 brought fresh analyst coverage and bullish sentiment despite some near-term selling pressure. ## Earnings Winners **$CRNX** - +98.7% - Beat expectations with strong Phase 3 data and announced a $10 billion acquisition by Vertex Pharmaceuticals, signaling robust growth potential in specialty pharma. **$TVRD** - +50% - Reported positive Phase 1 data for its next-gen STAT3 inhibitor, TTI-109, highlighting promising tolerability and target engagement. BTIG reiterated a Buy rating with a $15 price target. **$NKE** - data not available - Market expert commentary suggests positive momentum following recent earnings, supported by solid brand execution and growth prospects. **$SPCX** - data not available - Benefited from renewed investor interest in space and AI infrastructure themes, boosted by SpaceX’s Nasdaq-100 inclusion. ## Earnings Losers **$RIVN** - -10% - Shares fell sharply after announcing a 75 million-share public offering to raise capital. The company also pre-announced cautious Q2 revenue guidance, raising concerns about near-term growth and dilution. **$MU** - data not available - Despite a massive $50 billion revenue announcement, investor sentiment soured amid worries about the sustainability of the memory market cycle. **$SAN** (Sandisk) - -14% in a day - Shares plunged amid fears that the AI-driven memory boom may be cracking, reflecting concerns over demand sustainability and competitive pressures. **$SSNLF** (Samsung) - data not available - Despite reporting a 19-fold jump in quarterly profit fueled by AI demand, shares declined as investors questioned the lofty earnings expectations and broader chip sector outlook. ## After-Hours Earnings **$AMZN** - Results: data not available - The company is preparing a $25 billion bond sale to fund AI infrastructure investments. After-hours reaction is muted as investors await detailed Q2 results. **$GOOG / $GOOGL** - Results: data not available - Alphabet’s replacement of Verizon in the Dow Jones Industrial Average has drawn attention. Market experts are watching for earnings details and guidance updates. **$META** - Results: data not available - Meta faces a $1.4 trillion penalty scare related to youth safety litigation, with investors focused on AI integration and cost management. **$CRNX** - Results: acquisition deal details released - After-hours reaction positive, reflecting strong investor confidence in the Vertex acquisition. ## Earnings Themes Today - Revenue trends showed divergence, with specialty pharma and AI-related biotech companies reporting strong growth, while traditional semiconductor and EV sectors faced caution. - Margin commentary was mixed; some companies flagged margin pressures due to supply chain costs and competitive pricing, while others highlighted operational efficiencies and scale benefits. - Guidance tone leaned cautious overall, especially in capital-intensive sectors like EVs and semiconductors, where demand uncertainties and capital needs weighed on outlooks. Conversely, AI and biotech firms maintained or raised guidance reflecting robust pipeline progress and market opportunities. ## Tomorrow's Earnings Watch - **$JPM** - Before market open - Key metric to watch: revenue growth and trading segment performance amid a strong second quarter for banks. - **$BAC** - Before market open - Watch for earnings surprises and commentary on consumer lending and capital markets activity. - **$TSLA** - After market close - Focus on delivery numbers and margin outlook, especially in light of recent cautious investor sentiment. - **$NFLX** - After market close - Key to monitor subscriber growth and live programming revenue trends amid competitive streaming landscape. ## Key Takeaway Today's earnings underscore a bifurcated market environment where innovation-driven sectors like biotech and AI infrastructure continue to attract investor enthusiasm, while capital-intensive and cyclical industries face skepticism amid cautious guidance and capital raises. The sharp moves in Crinetics Pharmaceuticals and Tvardi Therapeutics highlight the premium investors place on pipeline progress and strategic deals. Conversely, the chip sector's mixed reaction to Samsung’s record profit and the selloff in Rivian shares reflect ongoing concerns about demand sustainability and dilution risks. As the market digests these results, attention will turn to tomorrow’s major bank reports and Tesla’s delivery update for further clues on economic resilience and growth trajectories.